Magnetic Resonance (MR) Imaging Study Using Ferumoxytol to Assess Early Tumor Response in Patients With Glioblastoma Multiforme - Contacts and Locations

Magnetic Resonance (MR) Imaging Study Using Ferumoxytol to Assess Early Tumor Response in Patients With Glioblastoma Multiforme

This study is currently recruiting participants.

Study NCT00660543. Last updated on October 3, 2008. Information provided by Oregon Health and Science University

Please refer to this study by its ClinicalTrials.gov identifier: NCT00660543

Contacts


Contact: Edward A Neuwelt, MD	503-494-5626	neuwelte@ohsu.edu

Contact: Nancy A Hedrick, BA	503-494-5626	hedrickn@ohsu.edu

Locations


United States, Oregon
	Oregon Health & Science University	Recruiting
	Portland, Oregon, United States, 97239
	Contact: Edward A Neuwelt, MD 503-494-5626 neuwelte@ohsu.edu
	Principal Investigator: Edward A Neuwelt, MD

Sponsors and Collaborators

Oregon Health and Science University

National Cancer Institute (NCI)

Investigators


Principal Investigator:	Edward A Neuwelt, MD	Oregon Health and Science University